
Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
Description
The Global Blood Collection Market was valued at USD 10.2 billion in 2024 and is estimated to grow at a CAGR of 6.1% to reach USD 18.3 billion by 2034.
The market growth is driven by the increasing prevalence of chronic diseases, growing demand for diagnostic testing, and the expansion of healthcare infrastructure globally. Blood collection plays a vital role in diagnostics, treatment planning, and transfusion services. Rising awareness regarding early disease detection and the adoption of preventive healthcare measures have significantly increased the volume of blood tests, pushing the demand for efficient and safe blood collection systems. Additionally, growing investments in healthcare research and personalized medicine are further accelerating the market’s growth.
Blood collection technologies have evolved to offer safer, minimally invasive, and user-friendly options for both patients and healthcare providers. Automation in blood collection, along with the development of vacuum-based and closed-loop systems, is reducing contamination risks and enhancing procedural efficiency. The emergence of liquid biopsy and genetic testing has also contributed to the rise in demand for high-quality blood samples. Governments and NGOs are increasingly supporting blood donation drives and awareness campaigns, especially in emerging economies where access to blood supply remains limited. The continued digitization of healthcare records and laboratory services is also streamlining blood collection, tracking, and analysis.
The consumables segment in the blood collection market generated USD 7.8 billion in 2024, driven by the consistent demand for single-use items such as blood collection tubes, needles, lancets, and blood bags across hospitals, diagnostic labs, and blood banks. These consumables are essential for routine diagnostic testing, transfusion procedures, and therapeutic applications, offering convenience, sterility, and safety.
In terms of application, diagnostic applications segment generated USD 5.15 billion in 2024. This growth is fueled by the rising incidence of infectious diseases, cancer, diabetes, and cardiovascular conditions, all of which require routine and precise blood diagnostics. Innovations in biomarker detection, point-of-care diagnostics, and advanced testing methodologies have expanded the role of blood-based diagnostics across preventive, curative, and prognostic care. The COVID-19 pandemic has also contributed to sustained demand for blood tests, with many health systems expanding their diagnostic capacities.
North America Blood Collection Market generated USD 3.6 billion in 2024, owing to its well-established healthcare infrastructure, high diagnostic testing rates, and strong regulatory support for safe blood collection practices. The region benefits from the presence of major market players, advanced hospital networks, and high public awareness regarding health screening and voluntary blood donation. Technological advancements such as barcode tracking systems, automated blood collection devices, and integrated laboratory information systems have further strengthened the market in the region. Moreover, collaborations between biotech firms, hospitals, and academic institutions are fostering innovation in blood collection methods tailored for advanced diagnostics and research.
Leading companies operating in the global blood collection market include Becton, Dickinson and Company (BD), Terumo Corporation, Greiner Bio-One, Haemonetics Corporation, and Sarstedt AG & Co. KG. These players are focusing on developing innovative, safer, and more efficient blood collection devices, including closed systems, vacuum-assisted technologies, and smart tracking tools. Strategic initiatives such as partnerships with healthcare providers, regional expansion, and investments in R&D are key to maintaining market leadership. With increasing healthcare demand and diagnostic sophistication worldwide, the blood collection market is poised for sustained growth, supporting the global push toward better health outcomes through timely and accurate testing.
The market growth is driven by the increasing prevalence of chronic diseases, growing demand for diagnostic testing, and the expansion of healthcare infrastructure globally. Blood collection plays a vital role in diagnostics, treatment planning, and transfusion services. Rising awareness regarding early disease detection and the adoption of preventive healthcare measures have significantly increased the volume of blood tests, pushing the demand for efficient and safe blood collection systems. Additionally, growing investments in healthcare research and personalized medicine are further accelerating the market’s growth.
Blood collection technologies have evolved to offer safer, minimally invasive, and user-friendly options for both patients and healthcare providers. Automation in blood collection, along with the development of vacuum-based and closed-loop systems, is reducing contamination risks and enhancing procedural efficiency. The emergence of liquid biopsy and genetic testing has also contributed to the rise in demand for high-quality blood samples. Governments and NGOs are increasingly supporting blood donation drives and awareness campaigns, especially in emerging economies where access to blood supply remains limited. The continued digitization of healthcare records and laboratory services is also streamlining blood collection, tracking, and analysis.
The consumables segment in the blood collection market generated USD 7.8 billion in 2024, driven by the consistent demand for single-use items such as blood collection tubes, needles, lancets, and blood bags across hospitals, diagnostic labs, and blood banks. These consumables are essential for routine diagnostic testing, transfusion procedures, and therapeutic applications, offering convenience, sterility, and safety.
In terms of application, diagnostic applications segment generated USD 5.15 billion in 2024. This growth is fueled by the rising incidence of infectious diseases, cancer, diabetes, and cardiovascular conditions, all of which require routine and precise blood diagnostics. Innovations in biomarker detection, point-of-care diagnostics, and advanced testing methodologies have expanded the role of blood-based diagnostics across preventive, curative, and prognostic care. The COVID-19 pandemic has also contributed to sustained demand for blood tests, with many health systems expanding their diagnostic capacities.
North America Blood Collection Market generated USD 3.6 billion in 2024, owing to its well-established healthcare infrastructure, high diagnostic testing rates, and strong regulatory support for safe blood collection practices. The region benefits from the presence of major market players, advanced hospital networks, and high public awareness regarding health screening and voluntary blood donation. Technological advancements such as barcode tracking systems, automated blood collection devices, and integrated laboratory information systems have further strengthened the market in the region. Moreover, collaborations between biotech firms, hospitals, and academic institutions are fostering innovation in blood collection methods tailored for advanced diagnostics and research.
Leading companies operating in the global blood collection market include Becton, Dickinson and Company (BD), Terumo Corporation, Greiner Bio-One, Haemonetics Corporation, and Sarstedt AG & Co. KG. These players are focusing on developing innovative, safer, and more efficient blood collection devices, including closed systems, vacuum-assisted technologies, and smart tracking tools. Strategic initiatives such as partnerships with healthcare providers, regional expansion, and investments in R&D are key to maintaining market leadership. With increasing healthcare demand and diagnostic sophistication worldwide, the blood collection market is poised for sustained growth, supporting the global push toward better health outcomes through timely and accurate testing.
Table of Contents
160 Pages
- Chapter 1 Methodology
- 1.1 Industry coverage
- 1.2 Market scope and definitions
- 1.3 Research design
- 1.4 Market size estimates and calculations
- 1.4.1 Approach 1: Company revenue share analysis
- 1.4.2 Approach 2: Volume-based approach
- 1.4.3 Approach 3: Demand side approach
- 1.5 Key trends for market estimates
- 1.6 Forecast model
- 1.7 Primary research & validation
- 1.7.1 Primary sources
- 1.7.2 Data mining sources
- 1.7.2.1 Paid sources
- 1.7.2.2 Public sources
- Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
- 2.1.1 Product type trends
- 2.1.2 Method trends
- 2.1.3 Application trends
- 2.1.4 End use trends
- 2.1.5 Regional trends
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of chronic and infectious diseases
- 3.2.1.2 Advancements in blood collection technologies
- 3.2.1.3 Increasing number of surgical procedures
- 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Risks associated with blood transfusions
- 3.2.2.2 Lack of skilled healthcare professionals
- 3.3 Growth potential analysis
- 3.3.2 By method
- 3.3.3 By application
- 3.3.4 By end use
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.5 Technological landscape
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
- Chapter 4 Competitive Landscape
- 4.1 Introduction
- 4.1.1 Becton, Dickinson and Company
- 4.1.2 Terumo Corporation
- 4.1.3 Nipro Corporation
- 4.2 Company market share analysis
- 4.3 U.S. revenue and volume analysis of key players at product level, 2024
- 4.3.1 Revenue analysis (USD Million)
- 4.3.2 Volume analysis (Units)
- 4.4 Company matrix analysis
- 4.5 Competitive analysis of major market players
- 4.6 Competitive positioning matrix
- 4.7 Strategy dashboard
- Chapter 5 Blood Collection Market, By Product Type
- 5.1 System
- 5.1.1 Automated systems
- 5.1.2 Manual systems
- 5.2 Consumables
- 5.2.1 Venous
- 5.2.1.1 Needles and syringes
- 5.2.1.1.1 Double-ended needles
- 5.2.1.1.2 Winged blood collection sets
- 5.2.1.1.3 Standard hypodermic needles
- 5.2.1.1.4 Other blood collection needles
- 5.2.1.2 Blood collection tubes
- 5.2.1.2.1 Serum-separating
- 5.2.1.2.2 EDTA
- 5.2.1.2.3 Heparin
- 5.2.1.2.4 Plasma-separating
- 5.2.1.3 Blood bags
- 5.2.1.4 Other venous products
- 5.2.2 Capillary
- 5.2.2.1 Lancets
- 5.2.2.2 Micro-container tubes
- 5.2.2.3 Micro-hematocrit tubes
- 5.2.2.4 Warming devices
- 5.2.2.5 Other capillary products
- Chapter 6 Blood Collection Market, By Method
- 6.1 Manual blood collection
- 6.2 Automated blood collection
- Chapter 7 Blood Collection Market, By Application
- 7.1 Diagnostics
- 7.2 Treatment
- 7.3 Research
- Chapter 8 Blood Collection Market, By End Use
- 8.1 Hospitals and clinics
- 8.2 Diagnostic centers
- 8.3 Blood banks
- 8.4 Academic and research institutes
- Chapter 9 Blood Collection Market, By Region
- 9.1 North America
- 9.2 Europe
- 9.3 Asia Pacific
- 9.4 Latin America
- 9.5 Middle East and Africa
- Chapter 10 Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Financial data
- 10.1.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.1.2 Product landscape
- 10.1.3 SWOT analysis
- 10.2 Becton, Dickinson and Company
- 10.2.1 Financial data
- 10.2.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.2.2 Product landscape
- 10.2.3 Strategic outlook
- 10.2.4 SWOT analysis
- 10.3 Cardinal Health, Inc.
- 10.3.1 Financial data
- 10.3.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.3.2 Product landscape
- 10.3.3 SWOT analysis
- 10.4 F. Hoffmann-La Roche Ltd.
- 10.4.1 Financial data
- 10.4.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.4.2 Product landscape
- 10.4.3 SWOT analysis
- 10.5 FL MEDICAL s.r.l.
- 10.5.1 Financial data
- 10.5.2 Product landscape
- 10.5.3 SWOT analysis
- 10.6 Fresenius SE & Co. KGaA
- 10.6.1 Financial data
- 10.6.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.6.2 Product landscape
- 10.6.3 SWOT analysis
- 10.7 Greiner AG
- 10.7.1 Financial data
- 10.7.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.7.2 Product landscape
- 10.7.3 SWOT analysis
- 10.8 Haemonetics Corporation
- 10.8.1 Financial data
- 10.8.1.1 Sales revenue, 2022-2025 (USD Million)
- 10.8.2 Product landscape
- 10.8.3 Strategic outlook
- 10.8.4 SWOT analysis
- 10.9 McKesson Corporation
- 10.9.1 Financial data
- 10.9.1.1 Sales revenue, 2022-2025 (USD Million)
- 10.9.2 Product landscape
- 10.9.3 SWOT analysis
- 10.10 Nipro Corporation
- 10.10.1 Financial data
- 10.10.1.1 Sales revenue, 2022-2025 (USD Million)
- 10.10.2 Product landscape
- 10.10.3 SWOT analysis
- 10.11 QIAGEN N.V.
- 10.11.1 Financial data
- 10.11.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.11.2 Product landscape
- 10.11.3 SWOT analysis
- 10.12 Sarstedt AG & Co. KG
- 10.12.1 Financial data
- 10.12.2 Product landscape
- 10.12.3 SWOT analysis
- 10.13 Siemens Healthineers AG
- 10.13.1 Financial data
- 10.13.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.13.2 Product landscape
- 10.13.3 SWOT analysis
- 10.14 Streck
- 10.14.1 Financial data
- 10.14.2 Product landscape
- 10.14.3 Strategic outlook
- 10.14.4 SWOT analysis
- 10.15 Terumo Corporation
- 10.15.1 Financial data
- 10.15.1.1 Sales revenue, 2022-2025 (USD Million)
- 10.15.2 Product landscape
- 10.15.3 Strategic outlook
- 10.15.4 SWOT analysis
- 10.16 Thermo Fisher Scientific, Inc.
- 10.16.1 Financial data
- 10.16.1.1 Sales revenue, 2021-2024 (USD Million)
- 10.16.2 Product landscape
- 10.16.3 SWOT analysis
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.